The effect of ethyl pyruvate on dapsone-induced methemoglobinemia in rats

Clinical Toxicology

Volumn 46, Issue 9, 2008, Pages 811-814

  Jo, You Hwan ^a   Kwon, Woon Yong ^a   Lee, Jeong Hoon ^b   Kim, Kyuseok ^c   Shin, Sang Do ^a   Kang, Young Joon ^d   Suh, Gil Joon ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Dongguk University Ilsan Hospital   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Jeju National University College of Medicine   (South Korea)

Author keywords

Antidote; Intoxication; Methemoglobinemia

Indexed keywords

ANTIOXIDANT; DAPSONE; PYRUVIC ACID ETHYL ESTER; RINGER LACTATE SOLUTION; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; METHEMOGLOBINEMIA; NONHUMAN; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIOXIDANTS; DAPSONE; FREE RADICAL SCAVENGERS; INJECTIONS, INTRAPERITONEAL; ISOTONIC SOLUTIONS; MALE; METHEMOGLOBINEMIA; OXIDATIVE STRESS; PYRUVATES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

RATTUS;

EID: 55949130016     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.1080/15563650802304419     Document Type: Article

References (31)

1. Pieters FA, Zuidema J. The absolute oral bioavailability of dapsone in dogs and humans. Int J Clin Pharmacol Ther Toxicol 1987; 25:396-400.
2. Paniker U, Levine N. Dapsone and sulfapyridine. Dermatol Clin 2001; 19:79-86.
3. Girad PM, Landman R, Gaudebout C, Olivares R, Saimot AG, Jelazko P, Certain A, Boue F, Bouvet E, Lecompte T, Coulaud JP, the PRIO Study Group. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med 1993; 328:1514-1520.
4. Uehleke H, Tabarelli S. N-hydroxylation of 4,4′- diaminodiphenylsulphone (Dapsone) by liver microsomes, and in dogs and humans. Naunyn Schmiedebergs Arch Pharmacol 1973; 278:55-68.
5. Watkins PB. Noninvasive tests of CYP3A enzymes. Pharmacogenetics 1994; 4:171-184.
6. 2-receptor antagonists on dapsone-induced methemoglobinemia in rats. Pharm Res 2002; 45:269-273.
7. Mitra AK, Thummel KE, Kalhorn TF, Kharasch ED, Unadkat JD, Slattery JT. Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo. Clin Pharmacol Ther 1995; 58:556-566.
8. Coleman MD, Rhodes LE, Scott AK, Verbov JL, Friedmann PS, Breckenridge AM, Park BK. The use of cimetidine to reduce dapsonedependent methaemoglobinemia in dermatitis herpetiformis patients. Br J Clin Pharmacol 1992; 34:244-249.
9. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med 1999; 34:646-656.
10. Jaffe ER, Hultquist DE. Cytochrome b5 reductase deficiency and enzymopenic hereditary methemoglobinemia. In: Scriver CR, Beaudet AL, Sly WS, et al., eds. The Metabolic and Molecular Basis of Inherited Disease, 7th ed. New York: McGraw-Hill, 1995:2267-2280.
11. Curry S. Methemoglobinemia. Ann Emerg Med 1982; 11:214-221.
12. Mansouri A, Lurie AA. Concise review: methemoglobinemia. Am J Hematol 1993; 42:7-12.
13. Harvey JW, Keitt AS. Studies of the efficacy and potential hazards of methylene blue therapy in aniline-induced methaemoglobinaemia. Br J Haematol 1983; 54:29-41.
14. Rosen PJ, Johnson C, McGehee WG, Beutler E. Failure of methylene blue treatment in toxic methemoglobinemia. Ann Intern Med 1971; 75:83-86.
15. Kirsch IR, Cohen HJ. Heinz body hemolytic anemia from the use of methylene blue in neonates. J Pediatr 1980; 96:276-278.
16. O'Donnell-Tormey J, Nathan CF, Lanks K, DeBoer CJ, de la Harpe J. Secretion of pyruvate: an antioxidant defense of mammalian cells. J Exp Med 1987; 165:500-514.
17. Brand K. Aerobic glycolysis by proliferating cells: protection against oxidative stress at the expense of energy yield. J Bioenerg Biomembr 1997; 29:355-364.
18. Brand KA, Hermfisse U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J 1997; 11:388-395.
19. 2 in vitro and in vivo and reduce menadioneinduced DNA injury and cytotoxicity. Am J Physiol 1995; 268:C227-C236.
20. Dobsak P, Courdertot-Masuyer C, Zeller M, Vergely C, Laubriet A, Assem M, Eicher JC, Teyssier JR, Wolf JE, Rochette L. Antioxidative properties of pyruvate and protection of the ischemic rat heart during cardioplegia. J Cardiovasc Pharmacol 1999; 34:651-659.
21. Bassenge E, Sommer O, Schwemmer M, Bunger R. Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state. Am J Physiol Heart Circ Physiol 2000; 279:H2431-2438.
22. Fink MP. Ethyl pyruvate: a novel anti-inflammatory agent. Crit Care Med 2003; 31:S51-S56.
23. Montgomery CM, Webb JL. Metabolic studies on heart mitochondria: II. The inhibitory action of parapyruvate on the tricarboxylic acid cycle. J Biol Chem 1956; 221:359-368.
24. Willems JL, de Kort AF, Vree TB, Trijbels JM, Veerkamp JH, Monnens LA. Non-enzymatic conversion of pyruvate in aqueous solution to 2,4-dihydroxy-2- methylglutaric acid. FEBS Lett 1978; 86:42-44.
25. Reade MC, Fink MP. Bench-to-bedside review: amelioration of acute renal impairment using ethyl pyruvate. Crit Care 2005; 9:556-560.
26. Wright RO, Magnani B, Shannon MW, Woolf AD. N-acetylcysteine reduces methemoglobin in vitro. Ann Emerg Med 1996; 28:499-503.
27. Wright RO, Woolf AD, Shannon MW, Magnani B. N-acetylcysteine reduces methemoglobin in an in vitro model of glucose-6-phosphate dehydrogenase deficiency. Acad Emerg Med 1998; 5:225-229.
28. Tanen DA, LoVecchio F, Curry SC. Failure of intravenous N-acetylcysteine to reduce methemoglobin produced by sodium nitrite in human volunteers: a randomized controlled trial. Ann Emerg Med 2000; 35:369-373.
29. Dotsch J, Demirakca S, Cryer A, Hanze J, Kuhl PG, Rascher W. Reduction of NO-induced methemoglobinemia requires extremely high doses of ascorbic acid in vitro. Intensive Care Med 1998; 24:612-615.
30. Matteucci MJ, Reed WJ, Tanen DA. Sodium thiosulfate fails to reduce nitrite-induced methemoglobinemia in vitro. Acad Emerg Med 2003; 10:299-302.
31. Linakis JG, Shannon M, Woolf A, Sax C. Recurrent methemoglobinemia after acute dapsone intoxication in a child. J Emerg Med 1989; 7:477-480.